ROTIPHORESE NF-Acrylamide/Bis-solution 40

Hazard statements (CLP)

H301, H315, H317, H319, H332, H340, H350, H361f, H372

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

Classification acc. to GHS Classification of the substance or mixture Classification acc. to GHS Section

Hazard categories

Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) Acute Tox. 3 H301 3.1I Acute toxicity (inhal.) Acute Tox. 4 H332 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 Section Cat- Hazard class and Hazard egory category statement 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 3.4S Skin sensitisation Skin Sens. 1 H317 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.7 Reproductive toxicity Repr. 2 H361f 3.9 Specific target organ toxicity - repeated exposure STOT RE 1 H372 For full text of abbreviations: see SECTION 16

Most important adverse effects

Delayed or immediate effects can be expected after short or long-term exposure

Signal word

Danger

Hazard pictograms

GHS06, GHS08

Hazard statements

H301 Toxic if swallowed H315 Causes skin irritation H317 May cause an allergic skin reaction H319 Causes serious eye irritation H332 Harmful if inhaled H340 May cause genetic defects H350 May cause cancer H361f Suspected of damaging fertility H372 Causes damage to organs through prolonged or repeated exposure

Prevention

P201 Obtain special instructions before use P280 Wear protective gloves/eye protection

Response

P301+P310 IF SWALLOWED: Immediately call a POISON CENTER/doctor P302+P352 IF ON SKIN: Wash with plenty of soap and water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P308+P313 IF exposed or concerned: Get medical advice/attention For professional users only

Hazardous Ingredients

Acrylamide, N,N'-Methylene bisacrylamide

Results of PBT and vPvB assessment

Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification acc. to GHS Section Hazard class Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) 3 Acute Tox. 3 H301 3.1I Acute toxicity (inhal.) 4 Acute Tox. 4 H332 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 Section Hazard class Cat- Hazard class and Hazard egory category statement 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.4S Skin sensitisation 1 Skin Sens. 1 H317 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.7 Reproductive toxicity 2 Repr. 2 H361f 3.9 Specific target organ toxicity - repeated exposure 1 STOT RE 1 H372 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.